A unique unresponsive CD4+ T cell phenotype post TCR antagonism

Cellular Immunology

Volumn 261, Issue 1, 2010, Pages 64-68

  Edwards, Lindsay J ^a   Evavold, Brian D ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CD4 T cells; Cytokines; Immune evasion

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLONAL ANERGY; CONTROLLED STUDY; CYTOKINE PRODUCTION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; INTERLEUKIN-2; MICE; MICE, TRANSGENIC; PEPTIDES; PHENOTYPE; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, INTERLEUKIN-2;

EID: 73649085433     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2009.11.002     Document Type: Article

References (34)

1. Sloan-Lancaster J., and Allen P.M. Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology. Annu. Rev. Immunol. 14 (1996) 1-27
2. De Magistris M.T., Alexander J., Coggeshall M., Altman A., Gaeta F.C.A., Grey H.M., and Sette A. Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor. Cell 68 (1992) 625-634
3. Jenkins M.K., and Schwartz R.H. Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J. Exp. Med. 165 (1987) 302-319
4. Jenkins M.K., Chen C., Jung G., Mueller D.L., and Schwartz R.H. Inhibition of antigen-specific proliferation of type 1 murine T cell clones after stimulation with immobilized anti-CD3 monoclonal antibody. J. Immunol. 144 (1990) 16-22
5. Quill H., and Schwartz R.H. Stimulation of normal inducer T cell clones with antigen presented by purified Ia molecules in planar lipid membranes: specific induction of a long-lived state of proliferation nonresponsiveness. J. Immunol. 138 (1987) 3704-3712
6. Korb L.C., Mirshahidi S., Ramyar K., Akha A.A.S., and Sadegh-Nasseri S. Induction of T cell anergy by low numbers of agonist ligands. J. Immunol. 163 (1999) 6401-6409
7. Ford M.L., and Evavold B.D. Regulation of polyclonal T cell responses by an MHC anchor-substituted variant of myelin oligodendrocyte glycoprotein 35-55. J. Immunol. 171 (2003) 1247-1254
8. Margot C.D., Ford M.L., and Evavold B.D. Amelioration of established experimental autoimmune encephalomyelitis by an MHC anchor-substituted variant of proteolipid protein 139-151. J. Immunol. 174 (2005) 3352-3358
9. Jameson S.C., and Bevan M.J. T cell receptor antagonists and partial agonists. Immunity 2 (1995) 1-11
10. LaFace D.M., Couture C., Anderson K., Shih G., Alexander J., Sette A., Mustelin T., Altman A., and Grey H.M. Differential T cell signaling induced by antagonist peptide-MHC complexes and the associated phenotypic responses. J. Immunol. 158 (1997) 2057-2064
11. Norris P.J., Stone J.D., Anikeeva N., Heitman J.W., Wilson I.C., Hirschkorn D.F., Clark M.J., Moffett H.F., Cameron T.O., Sykulev Y., Stern L.J., and Walker B.D. Antagonism of HIV-specific CD4+ T cells by C-terminal truncation of a minimum epitope. Mol. Immunol. 43 (2006) 1349-1357
12. Purbhoo M.A., Sewell A.K., Klenerman P., Goulder P.J., Hilyard K.L., Bell J.I., Jakobsen B.K., and Phillips R.E. Copresentation of natural HIV-1 agonist and antagonist ligands fails to induce the T cell receptor signaling cascade. Proc. Natl. Acad. Sci. USA 95 (1998) 4527-4532
13. Burroughs N.J., and Rand D.A. Dynamics of T-cell antagonism: enhanced viral diversity and survival. Proc. Biol. Sci. 265 (1998) 529-535
14. Frasca L., Del Porto P., Tuosto L., Marinari B., Scotta C., Carbonari M., Nicosia A., and Piccolella E. Hypervariable region 1 variants act as TCR antagonists for hepatitis C virus-specific CD4+ T cells. J. Immunol. 163 (1999) 650-658
15. Gilbert S.C., Plebanski M., Gupta S., Morris J., Cox M., Aidoo M., Kwiatkowski D., Greenwood B.M., Whittle H.C., and Hill A.V. Association of malaria parasite population structure, HLA, and immunological antagonism. Science 279 (1998) 1173-1177
16. Haque S.J., Harbor P., Tabrizi M., Yi T., and Williams B.R. Protein-tyrosine phosphatase Shp-1 is a negative regulator of IL-4- and IL-13-dependent signal transduction. J. Biol. Chem. 273 (1998) 33893-33896
17. Robertson J.M., and Evavold B.D. Cutting edge: dueling TCRs: peptide antagonism of CD4+ T cells with dual antigen specificities. J. Immunol. 163 (1999) 1750-1754
18. Dittel B.N., Stefanova I., Germain R.N., and Janeway Jr. C.A. Cross-antagonism of a T cell clone expressing two distinct T cell receptors. Immunity 11 (1999) 289-298
19. Yang W., and Grey H.M. Study of the mechanism of TCR antagonism using dual-TCR-expressing T cells. J. Immunol. 170 (2003) 4532-4538
20. Jones D.S., Reichardt P., Ford M.L., Edwards L.J., and Evavold B.D. TCR antagonism by peptide requires high TCR expression. J. Immunol. 181 (2008) 1760-1766
21. Stefanova I., Hemmer B., Vergelli M., Martin R., Biddison W.E., and Germain R.N. TCR ligand discrimination is enforced by competing ERK positive and SHP-1 negative feedback pathways. Nat. Immunol. 4 (2003) 248-254
22. Wylie D.C., Das J., and Chakraborty A.K. Sensitivity of T cells to antigen and antagonism emerges from differential regulation of the same molecular signaling module. Proc. Natl. Acad. Sci. USA 104 (2007) 5533-5538
23. Lipniacki T., Hat B., Faeder J.R., and Hlavacek W.S. Stochastic effects and bistability in T cell receptor signaling. J. Theor. Biol. 254 (2008) 110-122
24. Kersh G.J., Donermeyer D.L., Frederick K.E., White J.M., Hsu B.L., and Allen P.M. TCR transgenic mice in which usage of transgenic alpha- and beta-chains is highly dependent on the level of selecting ligand. J. Immunol. 161 (1998) 585-593
25. Kilgore N.E., Carter J.D., Lorenz U., and Evavold B.D. Cutting edge: dependence of TCR antagonism on Src homology 2 domain-containing protein tyrosine phosphatase activity. J. Immunol. 170 (2003) 4891-4895
26. Alexander J., Ruppert J., Snoke K., and Sette A. TCR antagonism and T cell tolerance can be independently induced in a DR-restricted, hemagglutinin-specific T cell clone. Int. Immunol. 6 (1994) 363-367
27. Bachmann M.F., Speiser D.E., Zakarian A., and Ohashi P.S. Inhibition of TCR triggering by a spectrum of altered peptide ligands suggests the mechanism for TCR antagonism. Eur. J. Immunol. 28 (1998) 3110-3119
28. Gebe J.A., Masewicz S.A., Kochik S.A., Reijonen H., and Nepom G.T. Inhibition of altered peptide ligand-mediated antagonism of human GAD65-responsive CD4+ T cells by non-antagonizable T cells. Eur. J. Immunol. 34 (2004) 3337-3345
29. Takato-Kaji R., Totsuka M., Ise W., Nishikawa M., Hachimura S., and Kaminogawa S. T-cell receptor antagonist modifies cytokine secretion profile of naive CD4+ T cells and their differentiation into type-1 and type-2 helper T cells. Immunol. Lett. 96 (2005) 39-45
30. Jenkins M.K., Taylor P.S., Norton S.D., and Urdahl K.B. CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells. J. Immunol. 147 (1991) 2461-2466
31. Furtado G.C., Curotto de Lafaille M.A., Kutchukhidze N., and Lafaille J.J. Interleukin 2 signaling is required for CD4(+) regulatory T cell function. J. Exp. Med. 196 (2002) 851-857
32. Yagi H., Nomura T., Nakamura K., Yamazaki S., Kitawaki T., Hori S., Maeda M., Onodera M., Uchiyama T., Fujii S., and Sakaguchi S. Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells. Int. Immunol. 16 (2004) 1643-1656
33. Wasserman H.A., Beal C.D., Zhang Y., Jiang N., Zhu C., and Evavold B.D. MHC variant peptide-mediated anergy of encephalitogenic T cells requires SHP-1. J. Immunol. 181 (2008) 6843-6849
34. Migone T.S., Cacalano N.A., Taylor N., Yi T., Waldmann T.A., and Johnston J.A. Recruitment of SH2-containing protein tyrosine phosphatase SHP-1 to the interleukin 2 receptor; loss of SHP-1 expression in human T-lymphotropic virus type I-transformed T cells. Proc. Natl. Acad. Sci. USA 95 (1998) 3845-3850